BRIEF published on 10/22/2024 at 09:42, 1 month ago Dalata Hotel Group: Notification of Major Holdings Voting Rights Shareholder Structure Dalata Hotel Group Equity Swaps JPMorgan Chase & Co.
PRESS RELEASE published on 10/22/2024 at 09:37, 1 month ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* JPMorgan Chase & Co. notified Dalata Hotel Group PLC of holding 5.46% voting rights on 17th Oct 2024 Acquisition Voting Rights Dalata Hotel Group Plc Notification Of Major Holdings JPMorgan Chase & Co.
BRIEF published on 10/22/2024 at 08:05, 1 month ago Dalata Hotel Group Engages in Share Buyback Voting Rights Share Buyback Programme Euronext Dublin Dalata Hotel Group Market Regulation
PRESS RELEASE published on 10/22/2024 at 08:00, 1 month ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC announces the purchase of 88,552 of its ordinary shares on Euronext Dublin as part of the Share Buyback Programme Voting Rights Ordinary Shares Share Buyback Programme Euronext Dublin Dalata Hotel Group Plc
BRIEF published on 10/21/2024 at 08:05, 1 month 1 day ago Dalata Hotel Group Conducts Share Buyback Voting Rights Share Buyback Market Abuse Regulation Euronext Dublin Dalata Hotel Group
PRESS RELEASE published on 10/21/2024 at 08:00, 1 month 1 day ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC announces the purchase of 127,672 of its ordinary shares through a share buyback program on 18/10/2024 Voting Rights Ordinary Shares Share Buyback Euronext Dublin Dalata Hotel Group Plc
BRIEF published on 10/18/2024 at 17:20, 1 month 3 days ago Dalata Hotel Group PLC: Significant Change in Shareholding Voting Rights FMR LLC Financial Instruments Shareholding Change Dalata Hotel Group
PRESS RELEASE published on 10/18/2024 at 17:15, 1 month 3 days ago Dalata Hotel Group PLC: HOL-Holding(s) in Company* FMR LLC notification of 7.05% voting rights in Dalata Hotel Group PLC on 17th October 2024 Acquisition Voting Rights Notification FMR LLC Dalata Hotel Group Plc
BRIEF published on 10/18/2024 at 08:05, 1 month 4 days ago Dalata Hotel Group Executes Share Buyback Voting Rights Ordinary Shares Share Buyback Euronext Dublin Dalata Hotel Group
PRESS RELEASE published on 10/18/2024 at 08:00, 1 month 4 days ago Dalata Hotel Group PLC: POS-Transaction in Own Shares Dalata Hotel Group PLC purchased 130,434 of its ordinary shares on 17/10/2024 through a share buyback program. The Group will cancel the repurchased shares Ordinary Shares Share Buyback Program Cancellation Dalata Hotel Group Plc Repurchased Shares
Published on 11/22/2024 at 09:00, 1 hour 46 minutes ago Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 10 hours 46 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 12 hours 41 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 12 hours 56 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 14 hours 31 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/22/2024 at 09:45, 1 hour 1 minute ago The GSMA – China Unicom Open Gateway Global Use Case Innovation Challenge has begun!
Published on 11/22/2024 at 09:23, 1 hour 23 minutes ago Turkiye Garanti Bankasi A.S.: Announcement regarding issuance of subordinated notes
Published on 11/22/2024 at 09:06, 1 hour 40 minutes ago Original-Research: NFON AG (von NuWays AG): Buy
Published on 11/21/2024 at 06:58, 1 day 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 17 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
